Medizone Intl. (fka MZEIQ)

[jackcross18]

teq0904,

posters on this board were discussing two years ago whether MZEI product was more cost effective than Xenex's or any other potential products out there. Sure maybe MZEI's product is more effective than others, but could a hospital get by with a another product based on lower cost. That's pretty much a standard type question to ask.

your statement:

Canadian hospitals aren't interested in it. I already knew that before I confirmed it with IR. Not because it doesn't kill but because there isn't a cost benefit study on the novel product

stunned me because common sense tells me that before marketing a product to a hospital you have to explain how it will benefit them.

The notion that marketing agreements have been signed with two separate companies and there is no cost benefit analysis done is amazing.

Did IR confirm this fact. If so, do you know what basis these companies are trying to market MZEI's product ?